{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:14:33Z","timestamp":1768274073963,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.pharma.2017.11.004","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T17:34:08Z","timestamp":1517506448000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quel bilan \u00e0 deux ans de la mise en place de l\u2019accompagnement des patients trait\u00e9s par anti-vitamines K\u00a0? Le point de vue du pharmacien d\u2019officine"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-4049","authenticated-orcid":false,"given":"C.","family":"Mongaret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lestrille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5139-7034","authenticated-orcid":false,"given":"F.","family":"Slimano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2017.11.004_bib0130","first-page":"1","article-title":"Les \u00e9v\u00e9nements ind\u00e9sirables graves dans les \u00e9tablissements de sant\u00e9\u00a0: fr\u00e9quence, \u00e9vitabilit\u00e9 et acceptabilit\u00e9","volume":"761","author":"Michel","year":"2011","journal-title":"DRESS"},{"key":"10.1016\/j.pharma.2017.11.004_bib0135","series-title":"Prise en charge des surdosages en antivitamines K, des situations \u00e0 risque h\u00e9morragique et des accidents h\u00e9morragiques chez les patients trait\u00e9s par antivitamines K en ville et en milieu hospitalier-synth\u00e8se des recommandations professionnelles","year":"2008"},{"key":"10.1016\/j.pharma.2017.11.004_bib0140","unstructured":"Pr\u00e9vention des h\u00e9morragies provoqu\u00e9es par les traitements anticoagulants anti-vitamine K (AVK) [Internet\u00a0; disponible sur\u00a0: http:\/\/www.ansm.sante.fr\/Dossiers\/Les-Anti-vitamine-K-AVK\/Prevention-des-hemorragies-provoquees-par-les-traitements-anticoagulants-anti-vitamine-K-AVK\/(offset)\/0#paragraph_1401\u00a0; consult\u00e9 le 14\u00a0avril 2017]."},{"key":"10.1016\/j.pharma.2017.11.004_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3917\/spub.253.0331","article-title":"Cooperation between general practitioners and pharmacists: a systematic review","volume":"25","author":"Michot","year":"2013","journal-title":"Sante Publique"},{"key":"10.1016\/j.pharma.2017.11.004_bib0150","first-page":"435","article-title":"Role of community pharmacists in therapeutic education of diabetic patients","volume":"6","author":"Bedhomme","year":"2012","journal-title":"Med Mal Metab"},{"key":"10.1016\/j.pharma.2017.11.004_bib0155","first-page":"49","article-title":"The community pharmacist in oncology, community collaboration for optimal dispensing","volume":"56","author":"Sicard","year":"2017","journal-title":"Actualites Pharm"},{"key":"10.1016\/j.pharma.2017.11.004_bib0160","first-page":"30","article-title":"Therapeutic education of elderly patients under antivitamin\u00a0\u2014\u00a0K treatment: evaluation of the program after 5\u00a0years","volume":"3","author":"Thiriat","year":"2014","journal-title":"J Pharm Belg"},{"key":"10.1016\/j.pharma.2017.11.004_bib0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharma.2014.02.004","article-title":"Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course","volume":"72","author":"Conort","year":"2014","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2017.11.004_bib0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0003-3928(03)00096-9","article-title":"Evaluation of an education program of patients undergoing oral anticoagulation treatment","volume":"52","author":"Saligari","year":"2003","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.pharma.2017.11.004_bib0175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0398-0499(04)96737-6","article-title":"Impact of an education program on patient behaviour favoring prevention of drug-related adverse events: a pilot study in patients receiving oral anticoagulants for thromboembolic venous disease","volume":"29","author":"L\u00e9ger","year":"2004","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.pharma.2017.11.004_bib0180","article-title":"Arr\u00eat\u00e9 du 28\u00a0novembre 2016\u00a0relatif aux bonnes pratiques de dispensation des m\u00e9dicaments pour les pharmacies d\u2019officine, les pharmacies mutualistes et les pharmacies de secours mini\u00e8res","year":"2016","journal-title":"JO"},{"key":"10.1016\/j.pharma.2017.11.004_bib0185","article-title":"Loi no\u00a02009-879\u00a0du 21\u00a0juillet\u00a02009\u00a0sur l\u2019h\u00f4pital et relative aux patients, \u00e0 la sant\u00e9 et aux territoires","year":"2009","journal-title":"JO"},{"key":"10.1016\/j.pharma.2017.11.004_bib0190","article-title":"Arr\u00eat\u00e9 du 4\u00a0mai\u00a02012\u00a0relatif \u00e0 la convention nationale organisant les rapports entre les pharmaciens titulaires d\u2019officine et l\u2019assurance maladie","year":"2012","journal-title":"JO"},{"key":"10.1016\/j.pharma.2017.11.004_bib0195","year":"2013","journal-title":"JO"},{"key":"10.1016\/j.pharma.2017.11.004_bib0200","article-title":"Arr\u00eat\u00e9 du 24\u00a0juin 2016\u00a0relatif aux avenants 8\u00a0et 9\u00a0de la convention nationale du 4\u00a0mai 2012, organisant les rapports entres les pharmaciens titulaires d\u2019officine et l\u2019assurance maladie","year":"2016","journal-title":"JO"},{"key":"10.1016\/j.pharma.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/jth.12107","article-title":"Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis","volume":"11","author":"Wong","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.pharma.2017.11.004_bib0210","series-title":"Entretiens pharmaceutiques AVK\u00a0: apr\u00e8s 1\u00a0an, adh\u00e9sion des pharmaciens et satisfaction des patients","author":"Paitraud","year":"2014"},{"key":"10.1016\/j.pharma.2017.11.004_bib0215","unstructured":"Enqu\u00eate USPO \u00ab\u00a0Entretiens pharmaceutiques AVK et Asthme 384\u00a0r\u00e9ponses de pharmaciens d\u2019officine du 10\u00a0avril au 22\u00a0mai\u00a02015\u00a0\u00bb [Internet\u00a0; disponible http:\/\/www.uspo.fr\/wp-content\/uploads\/2015\/06\/Asthme-resultats-mai-2015-USPO.pdf\u00a0; consult\u00e9 le 16\u00a0novembre\u00a02017]."},{"issue":"3","key":"10.1016\/j.pharma.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.respe.2017.01.002","article-title":"Cooperation according to French Law \u201chospital, patients, health and territories\u201d: Pharmacists\u2019 involvement in Aquitaine region","volume":"65","author":"d\u2019Elb\u00e9e","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.pharma.2017.11.004_bib0225","unstructured":"Suivi et accompagnement des patients diab\u00e9tiques de type 2\u00a0par le pharmacien d\u2019officine [Internet\u00a0; disponible sur\u00a0: http:\/\/www.ameli.fr\/professionnels-de-sante\/pharmaciens\/votre-caisse-loire-atlantique\/en-ce-moment\/suivi-et-accompagnement-des-patients-diabetiques_loire-atlantique.php\u00a0; consult\u00e9 le 14\u00a0avril 2017]."},{"key":"10.1016\/j.pharma.2017.11.004_bib0230","first-page":"113","article-title":"R\u00e9f\u00e9rentiels p\u00e9dagogiques en pharmacie et impact sur les pratiques professionnelles\u00a0: revue de la litt\u00e9rature fran\u00e7aise","volume":"27","author":"Planus","year":"2008","journal-title":"J Pharm Clin"},{"key":"10.1016\/j.pharma.2017.11.004_bib0235","article-title":"Pourquoi 70\u00a0% des entretiens n\u2019ont pas \u00e9t\u00e9 pay\u00e9","author":"Simon","year":"2017","journal-title":"Quot Pharm"},{"key":"10.1016\/j.pharma.2017.11.004_bib0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharma.2016.04.001","article-title":"Follow-up of patients treated by VKA: interest of a pharmaceutical link between the hospital and the retail pharmacies","volume":"75","author":"Bidon","year":"2017","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2017.11.004_bib0245","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2146\/ajhp040419","article-title":"Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy","volume":"62","author":"Benner","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pharma.2017.11.004_bib0125","unstructured":"Thelliez B. Patients sous AVK\u00a0: une meilleure observance gr\u00e2ce aux entretiens pharmaceutiques (10es\u00a0rencontres de l\u2019officine\u00a0\u2014\u00a04-6\u00a0mars\u00a02017) [Internet\u00a0; disponible sur\u00a0: http:\/\/www.jim.fr\/pharmacien\/pratique\/recherche\/e-docs\/patients_sous_avk_une_meilleure_observance_grace_aux_entretiens_pharmaceutiques_164246\/document_actu_pro.phtml\u00a0; consult\u00e9 le 14\u00a0avril\u00a02017]."}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:33:18Z","timestamp":1757719998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450917300676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0003450917300676"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2017.11.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quel bilan \u00e0 deux ans de la mise en place de l\u2019accompagnement des patients trait\u00e9s par anti-vitamines K\u00a0? Le point de vue du pharmacien d\u2019officine","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}